Viewing Study NCT06374459


Ignite Creation Date: 2025-12-24 @ 2:35 PM
Ignite Modification Date: 2025-12-25 @ 4:18 PM
Study NCT ID: NCT06374459
Status: RECRUITING
Last Update Posted: 2025-07-18
First Post: 2024-04-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis
Sponsor: Washington University School of Medicine
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module